NEW YORK, Oct. 21, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The Global Pharmacovigilance and Drug…
FREMONT, Calif., Oct. 21, 2024 /PRNewswire/ -- nCartes, Inc, a leader in EHR-to-EDC clinical trial data fulfillment, has gone live…
SHANGHAI and MIDDLETOWN, Del., Oct. 21, 2024 /PRNewswire/ -- HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company pioneering CRISPR-based programmable genome medicines,…
The analysis is being presented this week at the American College of Surgeons Clinical Congress 2024 (ACS 2024) in San…
MIAMI, FL / ACCESSWIRE / October 21, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is…
ZURICH, SWITZERLAND / ACCESSWIRE / October 21, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…
GENEVA, SWITZERLAND / ACCESSWIRE / October 21, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a…
NEW YORK, Oct. 19, 2024 /PRNewswire/ -- Kaia Health (Kaia), a leading digital health company, announces the appointment of Adam…
NX-5948 demonstrated robust clinical activity with objective responses observed in 7 of 9 (77.8%) evaluable Waldenstrom’s patients in the ongoing…
SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing…